Presbia PLC (NASDAQ:LENS) has earned a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy recommendation.

Analysts have set a twelve-month consensus price target of $8.00 for the company and are predicting that the company will post ($0.11) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Presbia an industry rank of 102 out of 255 based on the ratings given to related companies.

A number of equities analysts recently weighed in on LENS shares. Zacks Investment Research lowered shares of Presbia from a “hold” rating to a “sell” rating in a research note on Friday, August 31st. ValuEngine raised shares of Presbia from a “hold” rating to a “buy” rating in a research note on Thursday, July 5th. Finally, HC Wainwright set a $6.00 target price on shares of Presbia and gave the stock a “buy” rating in a research note on Tuesday, May 29th.

NASDAQ LENS traded down $0.02 on Thursday, reaching $1.76. The company had a trading volume of 1,695 shares, compared to its average volume of 8,797. Presbia has a 1-year low of $1.61 and a 1-year high of $7.14.

About Presbia

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in South Korea, Australia, New Zealand, Italy, the Netherlands, Ireland, Canada, and Germany.

Recommended Story: Outstanding Shares, Buying and Selling Stocks

Get a free copy of the Zacks research report on Presbia (LENS)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Presbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia and related companies with's FREE daily email newsletter.